R. Schelbergen

1.3k citations

22 papers · 1.0k indexed · h-index 11

Co-authors: Arjen B. Blom Peter L. E. M. van Lent Wim B. van den Berg Johannes Roth Thomas Vogl A. Sloëtjes W. de Munter Menno ter Huurne
Topics: Osteoarthritis Treatment and Mechanisms (18 papers)S100 Proteins and Annexins (18 papers)Inflammatory mediators and NSAID effects (7 papers)
Cited by: Rheumatology Genetics Urology
Journals: PLoS ONE International Journal of Molecular Sciences Annals of the Rheumatic Diseases
Partner nations: Netherlands Germany Sweden

In The Last Decade

R. Schelbergen

22 papers receiving 1.0k citations

Peers

Countries citing papers authored by R. Schelbergen

Since Specialization

Citations

This map shows the geographic impact of R. Schelbergen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Schelbergen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Schelbergen more than expected).

Fields of papers citing papers by R. Schelbergen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Schelbergen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Schelbergen. The network helps show where R. Schelbergen may publish in the future.

Co-authorship network of co-authors of R. Schelbergen

This figure shows the co-authorship network connecting the top 25 collaborators of R. Schelbergen. A scholar is included among the top collaborators of R. Schelbergen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Schelbergen. R. Schelbergen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Alarmin S100A9 Induces Proinflammatory and Catabolic Effects Predominantly in the M1 Macrophages of Human Osteoarthritic Synovium 2016 ·The Journal of Rheumatology ·M.H. van den Bosch,Arjen B. Blom,R. Schelbergen,Marije I. Koenders,F.A. van de Loo,Wim B. van den Berg,Thomas Vogl,Johannes Roth,P.M. van der Kraan,P.L. van Lent	56
2	Locally administered adipose derived mesenchymal stem cells reinforce their anti-inflammatory effect through IL-1β mediated attraction of neutrophils into knee joints with experimental osteoarthritis 2015 ·Osteoarthritis and Cartilage ·(unknown),R. Schelbergen,A. Sloëtjes,Niels A. J. Cremers,Menno ter Huurne,Frank A. D. T. G. Wagener,WB van den Berg,(unknown)	1
3	Prophylactic treatment with S100A9 inhibitor paquinimod reduces pathology in experimental collagenase-induced osteoarthritis 2015 ·Annals of the Rheumatic Diseases ·R. Schelbergen,E.J. Geven,Martijn H. J. van den Bosch,Helena Eriksson,Tomas Leanderson,Thomas Vogl,Johannes Roth,Fons A. J. van de Loo,Marije I. Koenders,P.M. van der Kraan,Wim B. van den Berg,Arjen B. Blom,Peter L. E. M. van Lent	71
4	Induction of Canonical Wnt Signaling by the Alarmins S100A8/A9 in Murine Knee Joints: Implications for Osteoarthritis 2015 ·Arthritis & Rheumatology ·M.H. van den Bosch,Arjen B. Blom,R. Schelbergen,Thomas Vogl,Johannes Roth,A. Sloëtjes,Wim B. van den Berg,P.M. van der Kraan,Peter L. E. M. van Lent	32
5	Alarmins S100A8/S100A9 stimulate osteophyte formation in experimental osteoarthritis and predict osteophyte progression in the check cohort of early human osteoarthritis patients 2014 ·Osteoarthritis and Cartilage ·R. Schelbergen,W. de Munter,M.H. van den Bosch,F.P. Lafeber,Thomas Vogl,Jürgen Röth,Wim B. van den Berg,P.M. van der Kraan,Arjen B. Blom,P.L. van Lent	2
6	Treatment efficacy of adipose-derived stem cells in experimental osteoarthritis is driven by high synovial activation and reflected by S100A8/A9 serum levels 2014 ·Osteoarthritis and Cartilage ·R. Schelbergen,(unknown),Menno ter Huurne,Johannes Roth,Thomas J. Vogl,Danièle Noël,C Jorgensen,(unknown),(unknown),Arjen B. Blom,Peter L. E. M. van Lent	69
7	The S100A9 inhibitor paquinimod (ABR-215757) reduces synovial activation, osteophyte formation and cartilage damage in experimental osteoarthritis 2014 ·Osteoarthritis and Cartilage ·R. Schelbergen,(unknown),Tomas Leanderson,Helena Eriksson,Wim B. van den Berg,P.M. van der Kraan,P.L. van Lent	1
8	OP0146 Alarmins S100a8/S100a9 Aggravate Osteophyte Formation in Experimental Osteoarthritis and PREDICT Osteophyte Progression in Early Human Osteoarthritis in the Dutch CHECK Cohort 2014 ·Annals of the Rheumatic Diseases ·R. Schelbergen,W. de Munter,(unknown),F.P. Lafeber,A. Sloëtjes,Thomas Vogl,Jürgen Röth,Wim B. van den Berg,P. van der Kraan,(unknown),(unknown)	4
9	Alarmins S100A8/S100A9 aggravate osteophyte formation in experimental osteoarthritis and predict osteophyte progression in early human symptomatic osteoarthritis 2014 ·Annals of the Rheumatic Diseases ·R. Schelbergen,W. de Munter,Martijn H. J. van den Bosch,F.P.J.G. Lafeber,A. Sloëtjes,Thomas Vogl,Johannes Roth,Wim B. van den Berg,P.M. van der Kraan,Arjen B. Blom,Peter L. E. M. van Lent	73
10	Curcumin-Induced Heme Oxygenase-1 Expression Prevents H2O2-Induced Cell Death in Wild Type and Heme Oxygenase-2 Knockout Adipose-Derived Mesenchymal Stem Cells 2014 ·International Journal of Molecular Sciences ·Niels A. J. Cremers,Ditte Lundvig,(unknown),R. Schelbergen,Peter van Lent,Walter A. Szarek,Raymond F. Regan,Carine Carels,Frank A. D. T. G. Wagener	35
11	Liposomal Targeting of Prednisolone Phosphate to Synovial Lining Macrophages during Experimental Arthritis Inhibits M1 Activation but Does Not Favor M2 Differentiation 2013 ·PLoS ONE ·(unknown),R. Schelbergen,Gert Storm,Wim B. van den Berg,P.L. van Lent	41
12	Alarmins S100A8/A9 cause osteophyte formation in experimental osteoarthritis with high synovial involvement 2013 ·Osteoarthritis and Cartilage ·R. Schelbergen,Arjen B. Blom,W. de Munter,A. Sloëtjes,Thomas Vogl,Johannes Roth,Wim B. van den Berg,P.L. van Lent	1
13	AB0073 The s100a9 inhibitor paquinimod (abr-215757) ameliorates experimental osteoarthritis with high synovial involvement 2013 ·Annals of the Rheumatic Diseases ·R. Schelbergen,Arjen B. Blom,Tomas Leanderson,Helena Eriksson,W. van den Berg,(unknown)	1
14	Alarmins S100A8 and S100A9 stimulate production of pro-inflammatory cytokines in M2 macrophages without changing their M2 membrane phenotype 2012 ·Osteoarthritis and Cartilage ·R. Schelbergen,(unknown),W. de Munter,Thomas Vogl,Johannes Roth,Wim B. van den Berg,P.L. van Lent	1
15	Alarmins S100A8 and S100A9 stimulate production of pro-inflammatory cytokines in M2 macrophages without changing their M2 membrane phenotype 2012 ·Annals of the Rheumatic Diseases ·R. Schelbergen,Arjen B. Blom,W. de Munter,Thomas Vogl,Johannes Roth,Wim B. van den Berg,P.L. van Lent	3
16	Active involvement of alarmins S100A8 and S100A9 in the regulation of synovial activation and joint destruction during mouse and human osteoarthritis 2011 ·Arthritis & Rheumatism ·Peter L. E. M. van Lent,Arjen B. Blom,R. Schelbergen,A. Sloëtjes,Floris P. J. G. Lafeber,Willem F. Lems,H. Cats,Thomas Vogl,Johannes Roth,Wim B. van den Berg	165
17	Alarmins S100A8 and S100A9 elicit a catabolic effect in human osteoarthritic chondrocytes that is dependent on Toll‐like receptor 4 2011 ·Arthritis & Rheumatism ·R. Schelbergen,Arjen B. Blom,Martijn H. J. van den Bosch,A. Sloëtjes,Shahla Abdollahi‐Roodsaz,B Willem Schreurs,John S. Mort,Thomas Vogl,Johannes Roth,Wim B. van den Berg,Peter L. E. M. van Lent	161
18	S100A8 and S100A9 induce a catabolic shift in chondrocytes from human osteoarthritis patients 2011 ·Annals of the Rheumatic Diseases ·R. Schelbergen,(unknown),A. Sloëtjes,Thomas Vogl,Jürgen Röth,Wim B. van den Berg,(unknown)	1
19	S100A8 causes a shift toward expression of activatory Fcγ receptors on macrophages via toll‐like receptor 4 and regulates Fcγ receptor expression in synovium during chronic experimental arthritis 2010 ·Arthritis & Rheumatism ·P.L. van Lent,Lilyanne C. Grevers,R. Schelbergen,Arjen B. Blom,Jeroen Geurts,A. Sloëtjes,Thomas Vogl,Johannes Roth,Wim B. van den Berg	41
20	094 ACTIVE INVOLVEMENT OF “ALARMINS” S100A8 AND A9 IN REGULATION OF SYNOVIAL ACTIVATION AND JOINT DESTRUCTION DURING OSTEOARTHRITIS 2009 ·Osteoarthritis and Cartilage ·P.L. van Lent,Arjen B. Blom,R. Schelbergen,A. Sloëtjes,Wolfgang Nacken,Thomas Vogl,Johannes Roth,Wim B. van den Berg	1

About R. Schelbergen

R. Schelbergen is a scholar working on Rheumatology, Anatomy and Pharmacology, having authored 22 papers that have together received 1.0k indexed citations. Recurring topics across this work include Osteoarthritis Treatment and Mechanisms (18 papers), S100 Proteins and Annexins (18 papers) and Inflammatory mediators and NSAID effects (7 papers). The work is most often cited by research in Rheumatology (645 citations), Genetics (226 citations) and Urology (126 citations). R. Schelbergen has collaborated with scholars based in Netherlands, Germany and Sweden. Frequent co-authors include Arjen B. Blom, Peter L. E. M. van Lent, Wim B. van den Berg, Johannes Roth, Thomas Vogl, A. Sloëtjes, W. de Munter, Menno ter Huurne, Danièle Noël and Lilyanne C. Grevers. Their work appears in journals such as PLoS ONE, International Journal of Molecular Sciences and Annals of the Rheumatic Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact